Sypris Solutions Appoints Rebecca Eckert as Chief Accounting Officer and Controller-March 2024-www.financetom.com

Sypris Solutions Appoints Rebecca Eckert as Chief Accounting Officer and Controller

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sypris Solutions Appoints Rebecca Eckert as Chief Accounting Officer and Controller

Aug 20, 2024 8:28 AM

11:01 AM EDT, 08/20/2024 (MT Newswires) -- Sypris Solutions ( SYPR ) said Tuesday that it has appointed Rebecca Eckert, its current controller, to the position of vice president, chief accounting officer and controller.

The appointment is effective Nov. 1, the company said.

Price: 1.61, Change: +0.02, Percent Change: +1.26

Previous page： Permian Resources Shareholders Launch Public Offering of 51.8 Million Class A Shares Next page： Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Permian Resources Shareholders Launch Public Offering of 51.8 Million Class A Shares

May 13, 2024

09:31 AM EDT, 05/13/2024 (MT Newswires) -- Permian Resources ( PR ) said Monday that certain shareholders had launched a public offering of about 51.8 million of its Class A shares. The company said the sellers include certain affiliates of EnCap Investments, NGP Energy Capital Management, Pearl Energy Investments, Riverstone Investment Group, and a member of Permian's board. The oil...

Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program

May 13, 2024

09:31 AM EDT, 05/13/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) said Monday that it has signed an accelerated share repurchase agreement with investment bank Jefferies to buy back $35 million of its common stock. Collegium said it will execute the deal as part of a $150 million share repurchase program the board authorized in January. Following the completion...

AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders

May 13, 2024

09:34 AM EDT, 05/13/2024 (MT Newswires) -- AbbVie ( ABBV ) and Gilgamesh Pharmaceuticals said Monday that they have entered into an option-to-license agreement to develop neuroplastogens to treat psychiatric disorders. Development and commercialization activities will be led by AbbVie ( ABBV ) upon exercise of the option, according to the companies. Gilgamesh will get $65 million in upfront payment...

Update: Blackstone to Take Japan's I'rom Private at 50% Premium

May 13, 2024

09:32 AM EDT, 05/13/2024 (MT Newswires) -- (Updates with additional information) Blackstone (BX) said Monday its private equity funds and vehicles have entered a definitive agreement with the management of Japanese pharmaceutical services company I'rom Group to take it private. The asset management firm will offer to acquire I'rom shares at 2,800 yen ($17.96) per share -- about a 50%...